Glenview Capital Management 13F holdings, Q4 2023
Holdings as of December 31, 2023 · filings on SEC EDGAR · latest filing →
Glenview Capital Management disclosed 41 US equity positions worth $4.3bn in its Q4 2023 13F filing. The largest position was CI at 15.0% of the reported book, followed by THC and DXC. Against the Q3 2023 filing, it opened 6 new positions, added to 14 and reduced 17 among the top 41 holdings.
What did Glenview Capital Management own in Q4 2023? Top 41 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q3 2023 |
|---|---|---|---|---|---|---|---|
| 1 | CI THE CIGNA GROUP | Healthcare | 15.0% | $641.6m | 2,142,526 | 38% | added |
| 2 | THC TENET HEALTHCARE CORP | Healthcare | 13.6% | $585.1m | 7,742,322 | 13% | added |
| 3 | DXC DXC TECHNOLOGY CO | Technology | 6.9% | $297.5m | 13,006,623 | 34% | added |
| 4 | UHS UNIVERSAL HLTH SVCS INC | Healthcare | 6.0% | $259.4m | 1,701,416 | -3% | reduced |
| 5 | GPN GLOBAL PMTS INC | Industrials | 5.8% | $247.4m | 1,948,128 | 5% | added |
| 6 | CLVT CLARIVATE PLC | Technology | 5.3% | $228.3m | 24,651,047 | 22% | added |
| 7 | CTVA CORTEVA INC | Basic Materials | 5.2% | $225.2m | 4,698,725 | 117% | added |
| 8 | ALIGHT INC | 3.6% | $155.3m | 18,202,012 | 11% | added | |
| 9 | MCK MCKESSON CORP | Healthcare | 3.5% | $151.3m | 326,896 | -9% | reduced |
| 10 | FISV FISERV INC | 2.9% | $125.3m | 943,277 | -26% | reduced | |
| 11 | UBER UBER TECHNOLOGIES INC | Technology | 2.8% | $120.9m | 1,964,351 | -7% | reduced |
| 12 | EXPE EXPEDIA GROUP INC | Consumer Cyclical | 2.5% | $106.4m | 701,261 | -13% | reduced |
| 13 | AMZN AMAZON COM INC | Consumer Cyclical | 2.5% | $105.5m | 694,077 | -27% | reduced |
| 14 | MYGN MYRIAD GENETICS INC | Healthcare | 2.4% | $101.1m | 5,283,982 | 40% | added |
| 15 | BKD BROOKDALE SR LIVING INC | Healthcare | 2.3% | $98.6m | 16,944,673 | -9% | reduced |
| 16 | VVV VALVOLINE INC | Consumer Cyclical | 2.0% | $87.2m | 2,320,173 | -8% | reduced |
| 17 | ESI ELEMENT SOLUTIONS INC | Basic Materials | 2.0% | $87.1m | 3,762,620 | 35% | added |
| 18 | USFD US FOODS HLDG CORP | Consumer Defensive | 1.9% | $79.6m | 1,753,729 | -22% | reduced |
| 19 | HCA HCA HEALTHCARE INC | Healthcare | 1.6% | $68.1m | 251,516 | -24% | reduced |
| 20 | VTRS VIATRIS INC | Healthcare | 1.5% | $65.7m | 6,065,047 | – | new |
| 21 | CVS CVS HEALTH CORP | Healthcare | 1.4% | $58.9m | 746,144 | – | new |
| 22 | META META PLATFORMS INC | Communication Services | 1.3% | $55.6m | 157,140 | 185% | added |
| 23 | KNX KNIGHT-SWIFT TRANSN HLDGS IN | Industrials | 1.1% | $49.3m | 855,577 | -16% | reduced |
| 24 | CHTR CHARTER COMMUNICATIONS INC N | Communication Services | 1.1% | $45.4m | 116,933 | -32% | reduced |
| 25 | DUN & BRADSTREET HLDGS INC | 1.1% | $45.2m | 3,859,884 | 75% | added | |
| 26 | BC BRUNSWICK CORP | Consumer Cyclical | 0.8% | $34.9m | 360,677 | 41% | added |
| 27 | EVOLV TECHNOLOGIES HLDNGS IN | 0.6% | $26.4m | 5,599,039 | 22% | added | |
| 28 | BROOKDALE SR LIVING INC | 0.5% | $23.4m | 25,450,000 | 0% | held | |
| 29 | CAH CARDINAL HEALTH INC | Healthcare | 0.5% | $20.5m | 203,254 | -21% | reduced |
| 30 | ELV ELEVANCE HEALTH INC | Healthcare | 0.4% | $17.9m | 37,909 | 154% | added |
| 31 | INTC INTEL CORP | Technology | 0.4% | $17.3m | 344,263 | -84% | reduced |
| 32 | TEVA TEVA PHARMACEUTICAL INDS LTD | Healthcare | 0.4% | $16.8m | 1,604,633 | – | new |
| 33 | MRVL MARVELL TECHNOLOGY INC | Technology | 0.3% | $10.8m | 179,709 | – | new |
| 34 | DIGIMARC CORP NEW | 0.2% | $10.5m | 291,855 | -28% | reduced | |
| 35 | BFLY BUTTERFLY NETWORK INC | 0.2% | $8.7m | 8,033,501 | 0% | held | |
| 36 | OFIX ORTHOFIX MED INC | Healthcare | 0.2% | $6.7m | 500,000 | – | new |
| 37 | LIBERTY GLOBAL LTD | 0.1% | $3.1m | 176,110 | – | new | |
| 38 | CBUS CIBUS INC | 0.1% | $2.3m | 116,465 | -3% | reduced | |
| 39 | RPID RAPID MICRO BIOSYSTEMS INC | 0.0% | $975.5k | 1,318,288 | 0% | held | |
| 40 | DOMA HOLDINGS INC | 0.0% | $74.1k | 15,994 | -20% | reduced | |
| 41 | BUTTERFLY NETWORK INC | 0.0% | $60.0k | 1,713,333 | 0% | held |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.